LISTEN: To make big profits, drug companies turn to monopoly shenanigans
Yay weekend! Yay, a new episode of Signal podcast! And this week hosts Luke Timmerman and Meg Tirrell are delving into a favourite topic of mine: the machinations and (whisper it) shenanigans that drug companies deploy to maintain monopolies and handle competition – “the wiley and often nefariously creative ways the drug industry pulls shenanigans” as Meg describes them. At the centre of these tricks and fiddles is our old friend, the patent, and the cost to the health care system, insurance premium payers, and taxpayers can run into billions.